Found: 22
Select item for more details and to access through your institution.
iGlarLixi effectively reduces residual hyperglycaemia in Chinese people with type 2 diabetes on basal insulin: A post hoc analysis of the LixiLan‐L‐CN study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 12, p. 5942, doi. 10.1111/dom.15968
- By:
- Publication type:
- Article
New clinical and seasonal evidence of infections by Human Parainfluenzavirus.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2018, v. 37, n. 11, p. 2211, doi. 10.1007/s10096-018-3363-y
- By:
- Publication type:
- Article
Mineral Metabolism in Children: Interrelation between Vitamin D and FGF23.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 7, p. 6661, doi. 10.3390/ijms24076661
- By:
- Publication type:
- Article
Respiratory syncytial virus incidence and typing in the last six seasons in the north of Spain (Asturias). Genetic characterization during the SARS‐CoV‐2 pandemic.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 3, p. 1, doi. 10.1002/jmv.29499
- By:
- Publication type:
- Article
The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3791, doi. 10.1111/dom.15724
- By:
- Publication type:
- Article
Real‐world effectiveness and safety of insulin glargine 100 U/mL plus lixisenatide in adults with type 2 diabetes: An international, multicentre, 12‐month, prospective observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2811, doi. 10.1111/dom.15599
- By:
- Publication type:
- Article
Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the SoliMix trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2391, doi. 10.1111/dom.14825
- By:
- Publication type:
- Article
Improved patient‐reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2364, doi. 10.1111/dom.14822
- By:
- Publication type:
- Article
Efficacy and safety of iGlarLixi versus IDegAsp: Results of a systematic literature review and indirect treatment comparison.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2660, doi. 10.1111/dom.14518
- By:
- Publication type:
- Article
Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1221, doi. 10.1111/dom.14354
- By:
- Publication type:
- Article
Descripción clínica y epidemiológica de un brote grave de salmonelosis en una escuela infantil urbana.
- Published in:
- Revista Española de Quimioterapia, 2022, v. 35, n. 3, p. 265, doi. 10.37201/req/134.2021
- By:
- Publication type:
- Article
Variabilidad entre áreas sanitarias en el consumo extrahospitalario de antibióticos de uso sistémico en la población pediátrica del Principado de Asturias, España (2005-2018).
- Published in:
- Revista Española de Quimioterapia, 2021, v. 34, n. 2, p. 107, doi. 10.37201/req/108.2020
- By:
- Publication type:
- Article
Change on the Circulation of Respiratory Viruses and Pediatric Healthcare Utilization during the COVID-19 Pandemic in Asturias, Northern Spain.
- Published in:
- Children, 2022, v. 9, n. 10, p. 1464, doi. 10.3390/children9101464
- By:
- Publication type:
- Article
Knowledge Gap: Sacred Forest Conservation and Generational Shift in the North Pare Mountains, Tanzania.
- Published in:
- Stichproben (19928610), 2024, n. 46, p. 1, doi. 10.25365/phaidra.521_01
- By:
- Publication type:
- Article
Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
234-OR: Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Better Clinical Outcomes with IGlarLixi vs. Premix 70/30 in the SoliMix Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-234-OR
- By:
- Publication type:
- Article
1-LB: Advancing Therapy in Basal Insulin Users with Type 2 Diabetes (T2D): Hypoglycemia as a Function of HbA1c in the SoliMix Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1-LB
- By:
- Publication type:
- Article
118-LB: Efficacy and Safety of iGlarLixi vs. IDegAsp: Systematic Review and Indirect Treatment Comparison (ITC).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-118-LB
- By:
- Publication type:
- Article
749-P: Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial Outside Europe.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-749-P
- By:
- Publication type:
- Article
748-P: Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial in Participants in Europe.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-748-P
- By:
- Publication type:
- Article
747-P: Improved Treatment Perceptions with IGlarLixi vs. Premix Insulin in Type 2 Diabetes (T2D) Uncontrolled on Basal Insulin (BI) + Oral Antihyperglycemic Drugs (OADs): Patient-Reported Outcomes (PROs) of the SoliMix Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-747-P
- By:
- Publication type:
- Article
746-P: Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Nocturnal Hypoglycemia in the SoliMix Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-746-P
- By:
- Publication type:
- Article